Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of Series 20 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment
発行・処分する株式数
1,000,000 new shares (September 2026)
Terms of the stock acquisition rights
Exercise price
¥24.00 (exercise price for the applicable month). Details of the adjustment clause are not disclosed.
Number of Stock Acquisition Rights
The total number issued is calculated based on 10,000 rights, equivalent to 1.69% of the total number issued, but the number of rights itself is not disclosed. Unexercised balance at the end of the previous month: 409,499 rights; unexercised balance at present: 399,499 rights
Procedures under the Corporate Code of Conduct
The exercise ratio subject to the exercise restrictions is disclosed as the status of compliance with the exercise deadline under Article 434 of the Listing Regulations
Most recent equity financing
Timing 23 December 2025 / Type 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of Series 20 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment |
| Number of shares to be issued or disposed of | 1,000,000 new shares (September 2026) |
| Total number of issued shares | 283,667,319 shares (as of the end of the month preceding the applicable period) → Not disclosed |
| Exercise price | ¥24.00 (exercise price for the applicable month). Details of the adjustment clause are not disclosed. |
| Number of Stock Acquisition Rights | The total number issued is calculated based on 10,000 rights, equivalent to 1.69% of the total number issued, but the number of rights itself is not disclosed. Unexercised balance at the end of the previous month: 409,499 rights; unexercised balance at present: 399,499 rights |
| Procedures under the Corporate Code of Conduct | The exercise ratio subject to the exercise restrictions is disclosed as the status of compliance with the exercise deadline under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 23 December 2025 / Type 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in September 2026 of the Series 20 Stock Acquisition Rights issued on 23 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.